🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 115 of 200 · A–Z by INN

  1. mangafodipir

    TESLASCAN

    EMA: withdrawn

    V08CA05

  2. mangafodipir trisodium

    TESLASCAN

    INJECTION FDA: approved

  3. manganese chloride

    MANGANESE CHLORIDE IN PLASTIC CONTAINER

    INJECTION FDA: approved

  4. manganese chloride tetrahydrate

    LUMENHANCE

    ORAL FDA: approved

  5. manganese sulfate

    MANGANESE SULFATE

    INJECTION FDA: approved

  6. mannitol

    BRONCHITOL Milestone Pharmaceuticals

    IRRIGATION FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    R05CB16

  7. manufacturing

    NMPA: clinical trials

  8. maprotiline hydrochloride

    MAPROTILINE HYDROCHLORIDE Beam Therapeutics

    ORAL FDA: approved

  9. maralixibat

    LIVMARLI

    EMA: application withdrawn

    A05AX

  10. maralixibat chloride

    LIVMARLI Mirum Pharmaceuticals International B.V.

    ORAL FDA: approved · EMA: approved · PMDA: approved

    A05AX04

  11. maraviroc

    CELSENTRI ViiV Healthcare Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AX09

  12. margetuximab-cmkb

    MARGENZA

    INJECTION FDA: approved

  13. margetuximab-iv

    NMPA: clinical trials

  14. maribavir

    LIVTENCITY Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    J05AX10

  15. marstacimab

    HYMPAVZI

    EMA: approved · PMDA: approved

    B02BX11

  16. marstacimab-hncq

    HYMPAVZI

    SUBCUTANEOUS FDA: approved

  17. masct

    NMPA: clinical trials

  18. masitinib

    MASITINIB AB SCIENCE

    EMA: refused

    L01EX06

  19. masoprocol

    ACTINEX

    TOPICAL FDA: approved

  20. matching

    NMPA: clinical trials

  21. matrix-applied characterised autologous cultured chondrocytes

    MACI

    EMA: unknown

    M09AX02

  22. mavacamten

    CAMZYOS Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    C01EB

  23. mavorixafor

    XOLREMDI

    ORAL FDA: approved · EMA: approved

    L03AX24

  24. mazindol

    SANOREX

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources